KIN Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: a low first month and a published monthly price on compounded semaglutide or tirzepatide
KIN Health's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $169/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
KIN Health is the trading name of KIN Medical, Inc., a Delaware telehealth company whose prescribers come through MD Integrations. It sells compounded semaglutide and tirzepatide injections and names its pharmacy partners. New patients pay $99 for the first month on the starting dose, then $169 a month for semaglutide or $199 for tirzepatide, with no membership fee. The Terms warn that the tirzepatide price can rise as the dose goes up.
Is KIN Health legit?
Yes. KIN Health is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.4/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a KIN Health promo or coupon code?
KIN Health has no coupon code to enter. New patients are currently quoted $99 for the first month, then $169 a month, and the discount applies on its own. Coupon sites advertising a "KIN Health promo code" are not a source we can vouch for.
See how KIN Health compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to KIN Health
Editorial score · methodology
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
KIN Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $169/mo
- What's included
- Medication · Consult
- FDA status
- No FDA warning letters found
How KIN Health scores
Six columns, each one computed from something KIN Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.6/10$199/month is 20% below the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on KIN Health
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for KIN Health
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with KIN Health involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1KIN Health shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask KIN Health which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $169, tirzepatide $199. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that KIN Health serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting KIN Health
- KIN Health offers email support
Cancelling KIN Health
Taken from the terms KIN Health publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly; a GLP-1 cancellation takes effect at the end of the current billing cycle
- Refund policy
- "Once medication has shipped, all sales are final and no refunds are issued." Full refund if the provider finds treatment not clinically appropriate.
- Early-termination fee
- None
GLP-1 medications KIN Health offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
$99 for the first month for new patients on the starting dose, then $169 a month, with the provider consult, medication, supplies and messaging included and no membership fee.
$99 for the first month for new patients on the starting dose, then $199 a month. The marketing pages say the price is the same at every dose, but the Terms say tirzepatide pricing tiers can change with the dose.
Check the price yourself before you pay
Every figure here was read off KIN Health's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $169 a month, 10% below the $188 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $199 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to KIN Health
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What KIN Health charges
KIN Health advertises $99. That buys the first month. The standing rate is $169/month, and that is the one worth doing the math on, because the introductory figure applies once.
- Compounded semaglutide: $99 first month, then $169/month
- Compounded tirzepatide: $99 first month, then $199/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so KIN Health's $199 is genuinely below the middle, not just advertised that way.
Enhance MD, at about $169/month, is the closest like-for-like alternative we review.
What KIN Health dispenses
KIN Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
Safety and disclosure
KIN Health tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to KIN Health. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If KIN Health will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether KIN Health bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want a cheap way to find out whether the medication suits you before committing
Our read
KIN Health is a cheap way to start and an ordinary way to continue. Use the $99 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $169/month before you let it renew twice.
The Bottom Line
KIN Health's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay KIN Health
Starting at $99 a month. Check today's price, then start the intake.
Where KIN Health is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare KIN Health head to head
The sellers closest to KIN Health on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this KIN Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See KIN Health's current pricing
Plans start at $99 a month. Whether you qualify is a clinician's decision, made after your intake.